Roche Diagnostics Limited - Product Pipeline Analysis by GlobalData

VIEWS: 71 PAGES: 65

More Info
									                                  Roche Diagnostics Limited - Product Pipeline Analysis
     Reference Code: GDME1714PD                                                                                            Publication Date: MAY 2011



     Company Snapshot                                                  Company Overview
     Key Information
                                                                         Roche Diagnostics Limited (Roche Diagnostics), a division of F. Hoffmann-La
     Roche Diagnostics Limited, Key Facts                                Roche Ltd. is engaged in the research, development, manufacture and
                                                                         marketing of diagnostic products for the healthcare markets. It also
     Web Address                            www.roche.com
                                                                         manufactures research reagents and systems and supplies drugs for cancer
     Turnover (in USD Million)              10,014.40                    and transplantation for the in-vitro and virology markets. The company
                                                                         provides services to individuals and health professionals to detect, monitor
     Number of Employees                    26,194                       and manage their patients' medical conditions. Its products and services are
     Industry                               Pharmaceuticals and          offered to patients, healthcare professionals, hospital lab professionals,
                                            Healthcare                   researchers and pharmacists.
     Source:Primary / Secondary Research
     GlobalData



     Roche Diagnostics Limited Pipeline Products

      Roche Diagnostics Limited Key Pipeline Products by                 Roche Diagnostics Limited Key Pipeline Products by Therapy Area
      Equipment Type
     Equipment Type                          No of Products            Therapy Area                                                  No of Products
     Immuno Chemistry                                    20            Diabetes mellitus                                                         6
     Infectious Immunology                               13            Cytomegalovirus infection                                                   4
     Glucose Monitoring                                            4   Breast cancer                                                               3
     Genetic Testing                                               4   HIV infection                                                               2
     Women's Health                                                1   Sepsis                                                                      2
     Insulin Delivery                                              1   Atherosclerosis                                                             1
     Injectable Drug Delivery                                      1   Autoimmune disease                                                          1
     Source: Primary / Secondary Research                                Source: Primary / Secondary Research
     GlobalData                                                          GlobalData


     Roche Diagnostics Limited Key Pipeline Products by Equipment Type




     Source: Primary / Secondary Research
     GlobalData




     Roche Diagnostics Limited Key Pipeline Products by                  Roche Diagnostics Limited Key Pipeline Products by Trial Phase
     Development Stage
     Developmental Stage                    No of Products             Trial Phase                                                   No of Products
     Clinicals                                          24             Phase IV                                                  -
     Pre-Clinicals                                                     Phase III                                                 -
                                             -
     Early development                                            12   Phase II                                                  -
     In Approval Process                                          12   Phase I                                                   -
     Source: Primary / Secondary Research                                Source: Primary / Secondary Research
     GlobalData                                                          GlobalData
     Note : (-) indicates 'Not Available'                                Note : (-) indicates 'Not Available'




Roche Diagnostics Limited - Product Pipeline Analysis                                                                           Reference Code: GDME1714PD

Source : www.globalcompanyintelligence.com                                                                                                              Page 1
     Table of Contents
     Table of Contents................................................................................................................................................................................................................................................................... 2
     List of Tables .......................................................................................................................................................................................................................................................................... 5
     List of Figures......................................................................................................................................................................................................................................................................... 8
     Roche Diagnostics Limited - Business Description................................................................................................................................................................................................................ 9
     Key Facts ............................................................................................................................................................................................................................................................................. 10
     Roche Diagnostics Limited - Major Products and Services ................................................................................................................................................................................................. 11
           Roche Diagnostics Limited Pipeline Products by Equipment Type ............................................................................................................................................................................... 14
           Roche Diagnostics Limited Pipeline Products by Development Stage.......................................................................................................................................................................... 17
           Roche Diagnostics Limited Pipeline Products by Therapy Area ................................................................................................................................................................................... 20
           Roche Diagnostics Limited Pipeline Products by Trial Phase ....................................................................................................................................................................................... 22
           Roche Diagnostics Limited Pipeline Products by Milestone Summary ......................................................................................................................................................................... 24
           Accu-Chek Combo......................................................................................................................................................................................................................................................... 26
                 Product Status......................................................................................................................................................................................................................................................... 26
                 Product Description ................................................................................................................................................................................................................................................. 26
                 Accu-Chek Combo Clinical Trial ............................................................................................................................................................................................................................. 26
                 Product Patent Details ............................................................................................................................................................................................................................................ 28
           ACCU-Chek Inform II with RALS Plus Data Management System ............................................................................................................................................................................... 29
                 Product Status......................................................................................................................................................................................................................................................... 29
                 Product Description ................................................................................................................................................................................................................................................. 29
           Accu-Chek Mobile.......................................................................................................................................................................................................................................................... 29
                 Product Status......................................................................................................................................................................................................................................................... 29
                 Product Description ................................................................................................................................................................................................................................................. 29
                 Product Patent Details ............................................................................................................................................................................................................................................ 30
           Accu-Chek Nano............................................................................................................................................................................................................................................................ 30
                 Product Status......................................................................................................................................................................................................................................................... 30
                 Product Description ................................................................................................................................................................................................................................................. 30
                 Product Patent Details ............................................................................................................................................................................................................................................ 31
           CAP/CTM CMV Test...................................................................................................................................................................................................................................................... 31
                 Product Status......................................................................................................................................................................................................................................................... 31
                 Product Description ................................................................................................................................................................................................................................................. 31
           Cobas 4800 EGFR Mutation Test.................................................................................................................................................................................................................................. 32
                 Product Status......................................................................................................................................................................................................................................................... 32
                 Product Description ................................................................................................................................................................................................................................................. 32
           Cobas 4800 HER Family Expression Assay.................................................................................................................................................................................................................. 32
                 Product Status......................................................................................................................................................................................................................................................... 32
                 Product Description ................................................................................................................................................................................................................................................. 32
           Cobas 4800 KRAS Mutation Test.................................................................................................................................................................................................................................. 32
                 Product Status......................................................................................................................................................................................................................................................... 32
                 Product Description ................................................................................................................................................................................................................................................. 33
           Cobas 8000 Analyser Series-Cobas c 702.................................................................................................................................................................................................................... 33
                 Product Status......................................................................................................................................................................................................................................................... 33
                 Product Description ................................................................................................................................................................................................................................................. 33
           Cobas b 123 POC System............................................................................................................................................................................................................................................. 33
                 Product Status......................................................................................................................................................................................................................................................... 33
                 Product Description ................................................................................................................................................................................................................................................. 33
                 Product Milestone ................................................................................................................................................................................................................................................... 34
           Cobas c311-Cholinesterase(Acetyl) Assay ................................................................................................................................................................................................................... 34
                 Product Status......................................................................................................................................................................................................................................................... 34
                 Product Description ................................................................................................................................................................................................................................................. 34
           Cobas c311-Gentamicin Assay ..................................................................................................................................................................................................................................... 35
                 Product Status......................................................................................................................................................................................................................................................... 35
                 Product Description ................................................................................................................................................................................................................................................. 35
           Cobas c311-LSD Assay................................................................................................................................................................................................................................................. 35
                 Product Status......................................................................................................................................................................................................................................................... 35
                 Product Description ................................................................................................................................................................................................................................................. 35
           Cobas c311-Oral Fluid amp/methamp/MDMA Combo Assay ....................................................................................................................................................................................... 35
                 Product Status......................................................................................................................................................................................................................................................... 35
                 Product Description ................................................................................................................................................................................................................................................. 35
           Cobas c311-Oral Fluid Amphetamines Assay ............................................................................................................................................................................................................... 36
                 Product Status......................................................................................................................................................................................................................................................... 36

Roche Diagnostics Limited - Product Pipeline Analysis                                                                                                                                                                                                  Reference Code: GDME1714PD

Source : www.globalcompanyintelligence.com                                                                                                                                                                                                                                                     Page 2
             Product Description ................................................................................................................................................................................................................................................. 36
        Cobas c311-Oral Fluid Barbiturates Assay.................................................................................................................................................................................................................... 36
             Product Status......................................................................................................................................................................................................................................................... 36
             Product Description ................................................................................................................................................................................................................................................. 36
        Cobas c311-Oral Fluid Benzodiazepine Assay ............................................................................................................................................................................................................. 36
             Product Status......................................................................................................................................................................................................................................................... 36
             Product Description ................................................................................................................................................................................................................................................. 37
        Cobas c311-Oral Fluid Buprenorphine Assay ............................................................................................................................................................................................................... 37
             Product Status......................................................................................................................................................................................................................................................... 37
             Product Description ................................................................................................................................................................................................................................................. 37
        Cobas c501/e601 Anti-CMV IgG Test ........................................................................................................................................................................................................................... 37
             Product Status......................................................................................................................................................................................................................................................... 37
             Product Description ................................................................................................................................................................................................................................................. 37
             Product Patent Details ............................................................................................................................................................................................................................................ 38
        Cobas c501/e601 HIV Combi PT Test........................................................................................................................................................................................................................... 38
             Product Status......................................................................................................................................................................................................................................................... 38
             Product Description ................................................................................................................................................................................................................................................. 38
        Cobas c501/e601 Thyroglobulin Test ............................................................................................................................................................................................................................ 38
             Product Status......................................................................................................................................................................................................................................................... 38
             Product Description ................................................................................................................................................................................................................................................. 39
        Cobas MDM2 Expression Assay ................................................................................................................................................................................................................................... 39
             Product Status......................................................................................................................................................................................................................................................... 39
             Product Description ................................................................................................................................................................................................................................................. 39
        ER/PR Antibody For IHC Testing .................................................................................................................................................................................................................................. 39
             Product Status......................................................................................................................................................................................................................................................... 39
             Product Description ................................................................................................................................................................................................................................................. 39
        Integrated Modualar Analytics Toxo IgM Test ............................................................................................................................................................................................................... 40
             Product Status......................................................................................................................................................................................................................................................... 40
             Product Description ................................................................................................................................................................................................................................................. 40
             Product Patent Details ............................................................................................................................................................................................................................................ 40
        Integrated Modular Analytics anti-CMV IgG Test .......................................................................................................................................................................................................... 40
             Product Status......................................................................................................................................................................................................................................................... 40
             Product Description ................................................................................................................................................................................................................................................. 41
             Product Patent Details ............................................................................................................................................................................................................................................ 41
        Integrated Modular Analytics anti-CMV IgM Test .......................................................................................................................................................................................................... 41
             Product Status......................................................................................................................................................................................................................................................... 41
             Product Description ................................................................................................................................................................................................................................................. 41
             Product Patent Details ............................................................................................................................................................................................................................................ 42
        Integrated Modular Analytics CA 72-4 Test ................................................................................................................................................................................................................... 42
             Product Status......................................................................................................................................................................................................................................................... 42
             Product Description ................................................................................................................................................................................................................................................. 42
        Integrated Modular Analytics Hepatitis A Test............................................................................................................................................................................................................... 42
             Product Status......................................................................................................................................................................................................................................................... 42
             Product Description ................................................................................................................................................................................................................................................. 43
             Product Patent Details ............................................................................................................................................................................................................................................ 43
        Integrated Modular Analytics Hepatitis B Test............................................................................................................................................................................................................... 43
             Product Status......................................................................................................................................................................................................................................................... 43
             Product Description ................................................................................................................................................................................................................................................. 43
             Product Patent Details ............................................................................................................................................................................................................................................ 44
        Integrated Modular Analytics HIV Combi Test............................................................................................................................................................................................................... 44
             Product Status......................................................................................................................................................................................................................................................... 44
             Product Description ................................................................................................................................................................................................................................................. 44
             Product Patent Details ............................................................................................................................................................................................................................................ 44
        Integrated Modular Analytics IL-6 Test .......................................................................................................................................................................................................................... 45
             Product Status......................................................................................................................................................................................................................................................... 45
             Product Description ................................................................................................................................................................................................................................................. 45
        Integrated Modular Analytics Rubella IgM Test ............................................................................................................................................................................................................. 45
             Product Status......................................................................................................................................................................................................................................................... 45
             Product Description ................................................................................................................................................................................................................................................. 45
             Product Patent Details ............................................................................................................................................................................................................................................ 46
        Integrated Modular Analytics System Mycophenolic Acid Test ..................................................................................................................................................................................... 46
             Product Status......................................................................................................................................................................................................................................................... 46
             Product Description ................................................................................................................................................................................................................................................. 46


Roche Diagnostics Limited - Product Pipeline Analysis                                                                                                                                                                                         Reference Code: GDME1714PD

Source : www.globalcompanyintelligence.com                                                                                                                                                                                                                                            Page 3
                 Product Patent Details ............................................................................................................................................................................................................................................ 46
           Integrated Modular Analytics System-Homocysteine Test ............................................................................................................................................................................................ 47
                 Product Status......................................................................................................................................................................................................................................................... 
								
To top